PDL BioPharma, Inc. Repayment/Issuance of Debt (Net)

Repayment/Issuance of Debt (Net) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Repayment/Issuance of Debt (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Repayment/Issuance of Debt (Net) for the quarter ending June 29, 2020 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by NaN%
  • Annual Repayment/Issuance of Debt (Net) for 2019 was $-97.9 Million (a -22.58% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2018 was $-126 Million (a -2628.94% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2016 was $5 Million (a -102.56% decrease from previous year)
  • Twelve month Repayment/Issuance of Debt (Net) ending June 29, 2020 was $-117 Million (a -0.0% decrease compared to previous quarter)
  • Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -7.68% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 30 Dec '18
$-117 Million $-117 Million $-97.9 Million $-126 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Repayment/Issuance of Debt (Net) of PDL BioPharma, Inc.

Most recent Repayment/Issuance of Debt (Net)of PDLI including historical data for past 10 years.

Interactive Chart of Repayment/Issuance of Debt (Net) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.0 $-18.85
2019 $-97.89 $-97.89
2018 $0.0 $0.0 $0.0 $-126.45 $-126.45
2016 $30.0 $0.0 $0.0 $-25.0 $5.0
2015 $-68.01 $-25.0 $-180.05 $77.66 $-195.4
2014 $-45.04 $-18.75 $-18.75 $251.34 $168.81
2013 $74.17 $74.17
2012 $0.0 $-22.74 $-46.79 $-23.84 $-93.37
2011 $-171.0 $-26.36 $-27.08 $-20.31 $-244.75
2010 $58.74 $-29.93 $-138.13 $-121.94

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.